Stomach Cancer Forecast in 17 Major Markets 2016-2026 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/9cb27d/stomach_cancer) has announced the addition of the "Stomach Cancer Forecast in 17 Major Markets 2016-2026" report to their offering.

Stomach cancer is a broad term encompassing tumours arising in the stomach and includes gastric carcinoma which is a malignant epithelial-origin tumour commonly developing after prolonged periods of gastritis.

Stomach cancers tend to develop slowly over many years spreading in different ways. Long-term infection of the stomach with Helicobacter pylori may lead to inflammation (known as chronic atrophic gastritis) and pre-cancerous changes to the inner lining of the stomach.

Main features and co-morbidities associated with Stomach Cancer include:

  • History of stomach polyps or stomach lymphoma
  • Family history of stomach cancer
  • Colorectal cancer
  • Familial adenomatous polyposis
  • BRCA1/BRCA2 mutations
  • Megaloblastic (pernicious) anaemia or being blood type A

Reasons to buy:

  • Able to quantify patient populations in global Stomach Cancer's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of Stomach Cancer and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Stomach Cancer's incident population.
  • Identify sub-populations within Stomach Cancer which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Stomach Cancer patients.

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key Co-morbid Conditions/ Features Associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Incidence for Stomach Cancer

10. Stages and Grading of Stomach Cancer

11. Abbreviations used in the Report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

For more information visit http://www.researchandmarkets.com/research/9cb27d/stomach_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology